Yamada S, Nishii R, Oka S, Higashi T, Yagi M, Satow T, Suzuki T, Saiki M. FDG-PET a pivotal imaging modality for diagnosis of stroke-onset intravascular lymphoma. Arch Neurol. 67:366-7,2010.
Kobayashi M, Shikano N, Nishii R, Kiyono Y, Araki H, Nishi K, Oh M, Okudaira H, Ogura M, Yoshimoto M, Okazawa H, Fujibayashi Y, Kawai K. Comparison of the transcellular transport of FDG and D-glucose by the kidney epithelial cell line, LLC-PK1. Nucl Med Commun. 31: 141-6, 2010.
Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, Tamaki N, Iwaisako K, Kitamura K, Ikai I, Uemoto S. P-glycoprotein expression affects 18F- fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro. Int J Oncol. 2009 May;34(5):1303-12.
Hara T, Higashi T, Nakamoto Y, Suga T, Saga T, Ishimori T, Ishizu K, Kawashima H, Kawase S, Matsumoto K, Togashi K. Significance of chronic marked hyperglycemia on FDG-PET: is it really problematic for clinical oncologic imaging? Ann Nucl Med. 2009 Sep;23(7):657-69. Epub 2009 Aug 7.
Kuga N, Shikano N, Takamura N, Nishii R, Yamasaki K, Kobayashi M, Nagamachi S, Tamura S, Kawai K. Competitive displacement of serum protein binding of radio- pharmaceuticals with amino acid infusion investigated with N-isopropyl-p-123I-iodo- amphetamine. J Nucl Med. 50: 1378-83, 2009.
Schwartz DL, Powis G, Thitai-Kumar A, He Y, Bankson J, Williams R, Lemos R, Oh J, Volgin A, Soghomonyan S, Nishii R, Alauddin M, Mukhopadhay U, Peng Z, Bornmann W, Gelovani J. The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects. Mol Cancer Ther. 8: 947-58, 2009.
Yamauchi H, Nishii R, Higashi T, Kagawa S, Fukuyama H. Hemodynamic compromise as a cause of internal border-zone infarction and cortical neuronal damage in atherosclerotic middle cerebral artery disease. Stroke. 40: 3730-5, 2009.
Higashi T, Hatano E, Ikai I, Nishii R, Nakamoto Y, Ishizu K, Suga T, Kawashima H, Togashi K, Seo S, Kitamura K, Takada Y, Uemoto S. FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 37:468-82, 2010.
Kumada T, Nishii R, Higashi T, Oda N, Fujii T. Epileptic apnea in a trisomy 18 infant. Pediatr Neurol. 42: 61-4, 2010.
Nakatani K, Nakamoto Y, Saga T, Higashi T, Togashi K. The potential clinical value of FDG-PET for recurrent renal cell carcinoma. Eur J Radiol. 2009 Dec 14. PMID: 20015602 [Epub ahead of print]
Kamimura K, Nagamachi S, Wakamatsu H, Fujita S, Nishii R, Umemura Y, Ogita M, Komada N, Sakurai T, Inoue T, Fujimoto T, Nakajo M. Role of gastric distention with additional water in differentiating locally advanced gastric carcinomas from physiological uptake in the stomach on 18F-fluoro-2-deoxy-D-glucose PET. Nucl Med Commun. 30: 431-9, 2009.
Nagamachi S, Wakamatsu H, Kiyohara S, Fujita S, Futami S, Arita H, Nishii R, Tamura S, Kawai K. Usefulness of a deep-inspiration breath-hold 18F-FDG PET/CT technique in diagnosing liver, bile duct, and pancreas tumors. Nucl Med Commun. 30: 326-32, 2009.
Kudo T, Hata T, Kagawa S, Kishibe Y, Iwasaki J, Okazawa H. Differences in early-phase tracer distribution in lung between 11C-acetate and 13N-ammonia. Nucl Med Commun. 30:343-9,2009
Tatsuya Higashi, Etsuro Hatano, Ryuichi Nishii, Yuji Nakamoto, Koichi Ishizu, Kaori Togashi. FDG-PET as a Prognostic Predictor in the Early Therapeutic Evaluation of the Non-operative Treatment of Hepatocellular Carcinoma. 56th Annual Meeting of Society of Nuclear Medicine, June 15th, 2009; Toronto, Canada.
Tatsuya Higashi, Etsuro Hatano, Ryuichi Nishii, Yuji Nakamoto, Koichi Ishizu, Kaori Togashi. FDG PET as a Prognostic Predictor in the Early Post-Therapeutic Evaluation for Unresectable Hepatocellular Carcinoma. EANM’09 - Annual Congress of the European Association of Nuclear Medicine Barcelona, Oct10-14, 2009; Barcelona, Spain
Nishii R., Higashi R., Kagawa S., Kishibe Y., Takahashi M., Uehara Y., Nagamachi S., Arano Y., Kawai K. World Molecular Imaging Conference, Sep23-26, 2009; Montoreal, Canada
Nishii R., Mukhopadhyay U., Soghomonyan S., Balatoni J., Mawlawi O., Alauddin MM., Higashi T., Tong W., and Gelovani JG. Preclinical Assessment of F-18 FEAU PET Imaging in Monkey. The 56th SNM Annual Meetin Jun 13-17, 2009; Toronto, Canada
Nishii R., Kagawa S., Higashi T., Kishibe Y., Takahashi M., Uehara Y., Nagamachi S., Arano Y., Kawai K. Comparison of system A and system L amino acid transports in human pancreas with C-11 MeAIB and C-11 MET PET study. The 56th SNM Annual Meetin Jun 13-17, 2009; Toronto, Canada
Shinya Kagawa, Ryuichi Nishii, Tatsuya Higashi, Hiroyo Araki, Hiroyuki Okudaira, Tomoya Uehara, Masato Kobayashi, Mitsuyoshi Yoshimoto, Yasushi Arano, Keiichi Kawai : Characterisation of system A amino acid transport and system L: uptake mechanism of [14C]MeAIB and [3H]Methionine in human carcinomas. European Association of Nuclear Medicine(EANM)Congress. Oct 11, 2009; Barcelona, Spain
Nishii R., Higashi R., Kagawa S., Kishibe Y., Takahashi M., Uehara Y., Arano Y., Kawai K. AMINO ACID TRANSPORT IMAGING WITH C-11 MEAIB AND C-11 MET IN CLINICAL PET STUDY. 24th JSSX Annual Meeting. 平成21年11月27-29日 京都
Nishii R., Higashi R., Kagawa S., Kishibe Y., Takahashi M., Uehara Y., Kobayashi M., Nagamachi S., Arano Y., Kawai K. Amino Acid Transport Imaging Using PET in Clinical Application - [11C] MeAIB PET Imaging As A Marker of System A Amino Acid Transport -Symposium, Asian Federation for Pharmaceutical Sciences 2009(平成21)年10月15-18日 Fukuoka
Takai A, Toyoshima T, Uemura M, Kitawaki Y, Marusawa H, Hiai H, Yamada S, Okazaki IM, Honjo T, Chiba T, Kinoshita K. A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. Oncogene. 28:469-78, 2009.
Uemura M, Niwa Y, Kakazu N, Adachi N, Kinoshita K. Chromosomal manipulation by site-specific recombinases and fluorescent protein-based vectors. PLoS ONE 5: e9846, 2010
Takai A, Toyoshima T, Uemura M, Niwa Y, Marusawa H, Hiai H, Honjo T, Chiba T, Kinoshita K(発表者). A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. 21st IUBMB and 12th FAOBMB International Congress of Biochemistry and Molecular Biology. Aug 6, 2009; 上海,中国
Uemura M, Niwa Y, Kakazu N, Adachi N, Kinoshita K. Chromosomal manipulation by site-specific recombinases and fluorescent protein-based vectors. 21st IUBMB and 12th FAOBMB International Congress of Biochemistry and Molecular Biology. Aug 3, 2009; 上海,中国.
Kito T, Taki T, Hayashi Y, Nakamura K, Irino T, Osaka M. Transient abnormal myelopoiesis (TAM) in a newborn with Down syndrome followed by an acute myeloid leukemia: identification of the same structural chromosomal abnormality at both stage of TAM and leukemia. Cancer Genet. Cytogenet. 188: 99-102, 2009.
神経病態研究部門
英語論文
Fujimoto M, Takagi Y, Muraki K, Nozaki K, Yamamoto N, Tsuji M, Hashimoto N, Honjo T, Tanigaki K. RBP-J promotes neuronal differentiation and inhibits oligodendroglial development in adult neurogenesis. Dev Biol. 332(2):339-50, 2009.
Suzuki G, Harper KM, Hiramoto T, Sawamura T, Lee M, Kang G, Tanigaki K, Buell M, Geyer MA, Trimble WS, Agatsuma S, Hiroi N. Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice. Hum Mol Genet. 18(9):1652-60, 2009.
Alam MS, Maekawa Y, Kitamura A, Tanigaki K, Yoshimoto T, Kishihara K, Yasutomo K. Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A. 2010 Mar 15. [Epub ahead of print]
国際学会
Tanigaki K RBP-J promotes neuronal differentiation. The Notch Meeting. Sep 25, 2009; Greece.
国内学会
Tanigaki K RBP-J promotes neuronal differentiation. 第32回日本神経科学会 平成21年9月16日 名古屋
Tanigaki K RBP-J promotes neuronal differentiation. 第32回日本分子生物学会 平成21年12月9日 横浜